| Literature DB >> 30685833 |
Yung-Kang Chen1,2, Yun Yen3,4,5,6.
Abstract
Long non-coding RNA (lncRNA) Xist has emerged as a key modulator in dosage compensation by randomly inactivating one of the X chromosomes in mammals during embryonic development. Dysregulation of X chromosome inactivation (XCI) due to deletion of Xist has been proven to induce hematologic cancer in mice. However, this phenomenon is not consistent in humans as growing evidence suggests Xist can suppress or promote cancer growth in different organs of the human body. In this review, we discuss recent advances of XCI in human embryonic stem cells and provide an explanation for the seemingly contradictory roles of Xist in development of human cancer.Entities:
Keywords: Cancer stem cell; Competing endogenous RNA; Exosomes; Long non-coding RNA; MicroRNAs; X Chromosome inactivation; XACT non-coding RNA; XIST non-coding RNA
Mesh:
Substances:
Year: 2019 PMID: 30685833 DOI: 10.1007/s12015-019-9871-z
Source DB: PubMed Journal: Stem Cell Rev Rep ISSN: 2629-3277 Impact factor: 5.739